M11.17
Familial chondrocalcinosis, ankle and foot
Clinical Classification Guidelines
Medical Intelligence & Overview
Familial chondrocalcinosis, classified under ICD-10 code M11.17, is a hereditary condition characterized by the abnormal calcification of cartilage within the ankle and foot joints. This disorder is part of a broader group known as calcium pyrophosphate deposition disease (CPPD), which involves the accumulation of calcium pyrophosphate crystals in joint tissues. The familial aspect indicates that the condition tends to run in families, suggesting a genetic predisposition that contributes to its development. While it primarily affects the small joints of the ankle and foot, the condition can sometimes involve other joints, leading to discomfort and mobility issues.
Causes & Symptoms
Clinical Causes: Genetic mutations that affect cartilage metabolism and calcium regulation Inheritance pattern consistent with autosomal dominant or recessive traits (depending on specific family cases) Presence of hereditary factors that predispose cartilage tissues to abnormal calcium phosphate crystal deposition Potential environmental factors that may exacerbate or trigger symptoms in genetically predisposed individuals
Key Symptoms: Joint pain, especially after periods of inactivity or excessive use Swelling and tenderness around affected joints Reduced joint mobility or stiffness Presence of calcium deposits detectable via imaging studies Possible warmth or redness over involved joints Intermittent flare-ups with increased discomfort
Diagnostic & Treatment
Diagnosis Path: Diagnosis of familial chondrocalcinosis involves a combination of clinical evaluation, imaging studies, and laboratory tests. Physicians typically consider patient history, especially a positive family history, and conduct physical examinations focusing on the affected joints. Diagnostic imaging, such as X-rays, can reveal characteristic calcifications within cartilage. Additionally, joint fluid aspiration and analysis may detect calcium pyrophosphate crystals, confirming the condition. Blood tests might be performed to rule out other forms of arthritis or metabolic disorders that could mimic the symptoms. Genetic testing could also be considered to identify specific mutations associated with hereditary patterns.
Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation Corticosteroid injections directly into affected joints to alleviate severe symptoms Physical therapy to maintain joint mobility and strengthen surrounding muscles Application of ice or heat to reduce swelling and discomfort Lifestyle modifications, including weight management and activity adjustments Regular monitoring for disease progression and potential complications
Clinical Advice & FAQs
Billing Guidance
Is M11.17 a billable ICD-10 code?
Yes, M11.17 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.17?
Clinical documentation must specify the nature of Familial chondrocalcinosis, ankle and foot and any associated comorbidities for accurate reporting.
Cite this Clinical Reference